These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1081 related articles for article (PubMed ID: 35281490)

  • 41. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
    Zheng Y; Bonfili L; Wei T; Eleuteri AM
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
    Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
    J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting Gut Dysbiosis and Microbiome Metabolites for the Development of Therapeutic Modalities for Neurological Disorders.
    Wiefels MD; Furar E; Eshraghi RS; Mittal J; Memis I; Moosa M; Mittal R; Eshraghi AA
    Curr Neuropharmacol; 2024; 22(1):123-139. PubMed ID: 36200211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dietary polyphenols represent a phytotherapeutic alternative for gut dysbiosis associated neurodegeneration: A systematic review.
    Chatterjee A; Kumar S; Roy Sarkar S; Halder R; Kumari R; Banerjee S; Sarkar B
    J Nutr Biochem; 2024 Jul; 129():109622. PubMed ID: 38490348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of Gut Microbiota and Gut-Brain Interplay in Selected Diseases of the Central Nervous System.
    Doroszkiewicz J; Groblewska M; Mroczko B
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease.
    Kaur G; Behl T; Bungau S; Kumar A; Uddin MS; Mehta V; Zengin G; Mathew B; Shah MA; Arora S
    Curr Neuropharmacol; 2021; 19(2):233-247. PubMed ID: 32504503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut dysbiosis and neurological modalities: An engineering approach via proteomic analysis of gut-brain axis.
    Kandpal M; Varshney N; Rawal KS; Jha HC
    Adv Protein Chem Struct Biol; 2024; 140():199-248. PubMed ID: 38762270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Gut Microbiota and Alzheimer's Disease.
    Jiang C; Li G; Huang P; Liu Z; Zhao B
    J Alzheimers Dis; 2017; 58(1):1-15. PubMed ID: 28372330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What the Gut Tells the Brain-Is There a Link between Microbiota and Huntington's Disease?
    Wronka D; Karlik A; Misiorek JO; Przybyl L
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gut Microbiota, an Additional Hallmark of Human Aging and Neurodegeneration.
    Molinero N; Antón-Fernández A; Hernández F; Ávila J; Bartolomé B; Moreno-Arribas MV
    Neuroscience; 2023 May; 518():141-161. PubMed ID: 36893982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Gut Microbiome as a Regulator of the Neuroimmune Landscape.
    Yu LW; Agirman G; Hsiao EY
    Annu Rev Immunol; 2022 Apr; 40():143-167. PubMed ID: 34990209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dysbiosis and Alzheimer's Disease: Cause or Treatment Opportunity?
    Janeiro MH; Ramírez MJ; Solas M
    Cell Mol Neurobiol; 2022 Mar; 42(2):377-387. PubMed ID: 33400081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. From Microbes to Memories: Challenges and Future Perspectives Regarding the Gut-Brain Axis for Improved Cognitive Health in Alzheimer's.
    Franco CD; Sagar RS; Bokhari SFH
    Cureus; 2024 Jan; 16(1):e52795. PubMed ID: 38389631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Linking circadian rhythms to microbiome-gut-brain axis in aging-associated neurodegenerative diseases.
    Cheng WY; Ho YS; Chang RC
    Ageing Res Rev; 2022 Jun; 78():101620. PubMed ID: 35405323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of the Gut Microbiota on the Development of Neurodegenerative Diseases.
    Singh MP; Chakrabarty R; Shabir S; Yousuf S; Obaid AA; Moustafa M; Al-Shehri M; Al-Emam A; Alamri AS; Alsanie WF; Alhomrani M; Shkodina AD; Singh SK
    Mediators Inflamm; 2022; 2022():3300903. PubMed ID: 36248189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence.
    Liu X; Liu Y; Liu J; Zhang H; Shan C; Guo Y; Gong X; Cui M; Li X; Tang M
    Neural Regen Res; 2024 Apr; 19(4):833-845. PubMed ID: 37843219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbiota-Immune System Interactions in Human Neurological Disorders.
    Huang Q; Yu F; Liao D; Xia J
    CNS Neurol Disord Drug Targets; 2020; 19(7):509-526. PubMed ID: 32713337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders.
    Dopkins N; Nagarkatti PS; Nagarkatti M
    Immunology; 2018 Jun; 154(2):178-185. PubMed ID: 29392733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human gut microbiota and Parkinson's disease.
    Pant A; Bisht KS; Aggarwal S; Maiti TK
    Prog Mol Biol Transl Sci; 2022; 192(1):281-307. PubMed ID: 36280322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.